Comparison

IQVIA OCE vs Nject

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

IQVIA OCE

This solution connects sales, marketing, and medical teams in the life sciences industry. It offers mobile access, advanced intelligence, and digital marketing tools for multi-channel customer engagement.

Highlights
  • Orchestrated customer engagement
  • Mobile access for field teams
  • Advanced intelligence capabilities
  • Digital marketing tools
  • Multi-channel journey management
  • Integrated commercial ecosystem
Features
Read full description

IQVIA Orchestrated Customer Engagement (OCE) is a solution that connects sales, marketing, medical and other functions to help life sciences representatives transform to a new orchestrated commercial model. OCE supports customer-facing personas such as territory managers, medical science liaisons, key account managers and life sciences representatives with functionality that goes far beyond traditional personal engagement and marketing automation. OCE provides unmatched mobile access, advanced intelligence and digital marketing capabilities that enable brand marketers to run sophisticated multi-channel journeys and the field to trigger compliant digital touchpoints. OCE is part of an integrated commercial ecosystem that enables you to manage the end-to-end process of customer engagement.

About

Nject

This app serves as a comprehensive resource for aesthetic professionals. It offers tools for dilution calculations, facilitates partnerships, and provides a live forum with experts. Users can also find assistance with vascular occlusion and access other valuable information.

Highlights
  • Dilution Calculators
  • Partnership Facilitation
  • Live Expert Forum
  • Vascular Occlusion Help
Features
Currently charting
Read full description

Nject is a one stop shop for all your Aesthetics needs like: Dilution Calculators, Partnerships, Live Forum with experts, Vascular Occlusion help, and more...

Screenshots

IQVIA OCE4 screens
Nject4 screens

Verdict

The call

The clearest difference is price: IQVIA OCE at Free against Nject's $4.99. IQVIA OCE also leads on rating (4.2 vs 4.0). Nject's advantage is review sentiment (57% vs 32%) and chart position (#10 vs unranked). On update cadence, ads, in-app purchases and monetization model there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

IQVIA OCE is free to download; Nject costs $4.99 up front. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

IQVIA OCE holds the better App Store score, 4.2 against 4.0. Both are backed by a comparable volume of ratings — 35 and 126 respectively. Written reviews complicate that: 32% of IQVIA OCE's written reviews are positive against 57% of Nject's, so the app with the better star average is not the one people write more warmly about.

UpkeepUpdate frequency

IQVIA OCE ships an update monthly, Nject every 6 weeks. The most recent releases landed on October 17, 2026 and October 19, 2026 respectively.

Scorecard6 real differences · 5 level
IQVIA OCE versus Nject: the parameters behind the verdict, then further details
ParameterIQVIA OCENject
PriceFree — better$4.99
Rating4.2 (35 ratings) — better4.0 (126 ratings)
Positive reviews32.3% of reviews57.4% of reviews — better
Number of ratings35126 — better
Update frequencyMonthly — betterEvery 6 weeks
AdsNoNo
In-app purchasesNoNo
MonetizationFreeFree
Best chart rank—#10 — better
DevicesiPhone, iPad, Apple WatchiPhone, iPad, iPod
Requires iOS26.015.1 — better
Further details — not scored
Size460 MB68 MB
Age rating17+17+
DeveloperIQVIA Inc.Keaton Benning, LLC

Customer experience

IQVIA OCE

All ratings35 ratings
Positive77.1%
Neutral5.7%
Negative17.1%
Written reviews31 reviews
Positive32.3%
Neutral0.0%
Negative67.7%

Nject

All ratings126 ratings
Positive70.6%
Neutral8.7%
Negative20.6%
Written reviews68 reviews
Positive57.4%
Neutral10.3%
Negative32.4%

Bugs and requests

IQVIA OCE

Not enough reviews yet to summarise bugs or requests.

Nject

Reported bugs

10 issues
  • App crashes when selecting syringe option
  • Syringe dropdown menu fails to load options
  • Screen doesn't scroll to reveal calculate button after data entry
  • Force closing on both iOS and Android devices
  • Stuck on single medication screen (Semaglutide) with no navigation
Show 5 more
  • Info button repeatedly triggers review window instead of showing help
  • Semaglutide advertisement prevents completing calculations
  • Decimal point entry not functioning properly
  • App crashes after recent Semaglutide update
  • Incorrect Comfortox syringe image (shows insulin syringe instead)

Requested features

9 requests
  • Add Comfortox 0.5mL syringe option
  • Add TB (tuberculin) syringe options
  • Add allergen/product selection dropdown (Botox, Dysport, Azzalure, etc.)
  • Visual indicator showing exact pull location on syringe for specific units
  • Support for mg/mL dosing (for Semaglutide, tirzepatide, compounded medications)
Show 4 more
  • Removable Semaglutide advertisement
  • Back button for navigation
  • Improved syringe image clarity and accuracy
  • Support for more injectable medications beyond toxins

In-app purchases

None

IQVIA OCE

No in-app purchases

None

Nject

No in-app purchases

Questions

Is IQVIA OCE free?
IQVIA OCE is free to download, with no in-app purchases.
Is Nject free?
Nject costs $4.99, with no in-app purchases.
Which has better reviews, IQVIA OCE or Nject?
IQVIA OCE is rated higher. IQVIA OCE averages 4.2 out of 5 from 35 ratings, while Nject averages 4.0 from 126 ratings.
Do IQVIA OCE or Nject have ads?
Neither IQVIA OCE nor Nject shows ads.
Which is updated more often, IQVIA OCE or Nject?
IQVIA OCE ships an update monthly, and Nject every 6 weeks. Most recently, IQVIA OCE was updated on October 17, 2026 and Nject on October 19, 2026.

Other comparisons